Involvement of DR4/JNK pathway-mediated autophagy in acquired TRAIL resistance in HepG2 cells

Sung-Chul Lim1, Ho Jong Jeon1, Keun Hong Kee1

  • 1Department of Pathology, College of Medicine, Chosun University, Gwangju 61501, Republic of Korea.

Insights

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) resistance in cancer cells can be overcome by targeting protective autophagy. This study reveals TRAIL-induced autophagy mediated by DR4 in resistant HepG2 cells, offering new therapeutic strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cellular Biology

Background:

  • Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) shows promise as an anticancer agent.
  • TRAIL resistance is a significant challenge in cancer therapy, with mechanisms not fully understood.

Purpose of the Study:

  • To elucidate a novel mechanism of TRAIL resistance in hepatocellular carcinoma cells.
  • To investigate the role of autophagy and DR4 in TRAIL resistance.

Main Methods:

  • Generation of TRAIL-resistant HepG2 cells (HepG2-TR) by exposure to recombinant human TRAIL (rhTRAIL).
  • Assessment of apoptosis and cytotoxicity in response to rhTRAIL.
  • Inhibition of autophagy using 3-methyladenine and ATG5 knockdown.
  • Analysis of DR4 and c-Jun N-terminal kinase involvement.

Main Results:

  • HepG2-TR cells exhibited insensitivity to rhTRAIL and triggered autophagy.
  • Inhibition of autophagy partially restored rhTRAIL-induced apoptosis and cytotoxicity, indicating protective autophagy.
  • rhTRAIL-induced autophagy was mediated by DR4 in HepG2-TR cells, involving c-Jun N-terminal kinase.

Conclusions:

  • A novel mechanism of TRAIL resistance involving DR4-mediated, c-Jun N-terminal kinase-regulated autophagy has been identified.
  • These findings enhance the understanding of TRAIL resistance and suggest potential therapeutic targets.

Related Concept Videos

Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
6.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.9K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.0K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.1K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.2K